JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB191217

重组Anti-PARP1抗体[EPR18461]

Anti-PARP1 antibody [EPR18461]

  • KO Validated
  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • 了解详情

4

(6 Reviews)

|

(146 Publications)

Anti-PARP1 antibody [EPR18461] (ab191217) is a rabbit monoclonal antibody detecting PARP1 in Western Blot, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 80 publications

查看别名

ADPRT, PPOL, PARP1, Poly [ADP-ribose] polymerase 1, PARP-1, ADP-ribosyltransferase diphtheria toxin-like 1, DNA ADP-ribosyltransferase PARP1, NAD(+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1, Protein poly-ADP-ribosyltransferase PARP1, ARTD1, ADPRT 1

12 Images
Immunocytochemistry/ Immunofluorescence - Anti-PARP1 antibody [EPR18461] (AB191217)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-PARP1 antibody [EPR18461] (AB191217)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling PARP1 with ab191217 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing nuclear staining on HeLa cell line. The nuclear counterstain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/1000 dilution (red).

The negative controls are as follows : -
-ve control 1 : ab191217 at 1/500 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/1000 dilution.
-ve control 2 : Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARP1 antibody [EPR18461] (AB191217)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARP1 antibody [EPR18461] (AB191217)

Immunohistochemical analysis of paraffin-embedded Human testis tissue labeling PARP1 with ab191217 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Nucleus staining on epithelial cells and stromal cells of Human testis is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARP1 antibody [EPR18461] (AB191217)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARP1 antibody [EPR18461] (AB191217)

Immunohistochemical analysis of paraffin-embedded Mouse testis tissue labeling PARP1 with ab191217 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Nucleus staining on epithelial cells and stromal cells of mouse testis is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARP1 antibody [EPR18461] (AB191217)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARP1 antibody [EPR18461] (AB191217)

Immunohistochemical analysis of paraffin-embedded Rat testis tissue labeling PARP1 with ab191217 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Nucleus staining on epithelial cells and stromal cells of rat testis is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-PARP1 antibody [EPR18461] (AB191217)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-PARP1 antibody [EPR18461] (AB191217)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized NIH/3T3 (Mouse embryonic fibroblast cells) cells labeling PARP1 with ab191217 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing nuclear staining on NIH/3T3 cell line. The nuclear counterstain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) at 1/1000 dilution (red).

The negative controls are as follows : -
-ve control 1 : ab191217 at 1/500 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) at 1/1000 dilution.
-ve control 2 : Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)
  • WB

Supplier Data

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)

Blocking/Dilution buffer : 5% NFDM/TBST.

The lysates were prepared in 1%SDS Hot lysis method

All lanes:

Western blot - Anti-PARP1 antibody [EPR18461] (ab191217) at 1/1000 dilution

Lane 1:

Human fetal heart lysate at 10 µg

Lane 2:

Human fetal kidney lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/50000 dilution

Predicted band size: 113 kDa

Observed band size: 113 kDa

false

Exposure time: 15s

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)
  • WB

Supplier Data

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)

Blocking/Dilution buffer : 5% NFDM/TBST.

The expression profile observed is consistent with what has been described in the literature (PMID : 1536009).

The lysates were prepared in 1%SDS Hot lysis method

All lanes:

Western blot - Anti-PARP1 antibody [EPR18461] (ab191217) at 1/10000 dilution

Lane 1:

Untreated HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysates at 10 µg

Lane 2:

HeLa (Human epithelial cells from cervix adenocarcinoma) treated with 1uM staurosporine for 4 hours whole cell lysates at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/50000 dilution

Predicted band size: 113 kDa

Observed band size: 113 kDa,89 kDa

false

Exposure time: 5s

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)
  • WB

Unknown

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)

The lysates were prepared in 1%SDS Hot lysis method.

Blocking/diluting buffer & concentration : 5% NFDM/TBST

Observed MW : 112 kDa

All lanes:

Western blot - Anti-PARP1 antibody [EPR18461] (ab191217) at 1/1000 dilution

Lane 1:

Rat brain lysates prepared in RIPA lysis method at 15 µg

Lane 2:

Rat brain lysates prepared in 1%SDS Hot lysis method at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/20000 dilution

Predicted band size: 113 kDa

false

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)
  • WB

Lab

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)

Western blot : Anti-PARP1 antibody [EPR18461] (ab191217) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab191217 was shown to bind specifically to PARP1. A band was observed at 125 kDa in wild-type A549 cell lysates with no signal observed at this size in PARP1 knockout cell line ab276094 (knockout cell lysate Abcam Pools). To generate this image, wild-type and PARP1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-PARP1 antibody [EPR18461] (ab191217) at 1/1000 dilution

Lane 1:

Wild-type A549 control staurosporine (0 uM, 72 h) cell lysate at 20 µg

Lane 2:

Wild-type A549 treated staurosporine (3 uM, 24 h) cell lysate at 20 µg

Lane 3:

PARP1 knockout A549 control staurosporine (0 uM, 72 h) cell lysate at 20 µg

Lane 4:

PARP1 knockout A549 treated staurosporine (3 uM, 24 h) cell lysate at 20 µg

Lane 5:

Empty cell lysate at 20 µg

Lane 6:

HAP1 Treated Staurosporine (2uM, 4h) cell lysate at 20 µg

Lane 7:

HAP1 Vehicle Control Staurosporine (0uM, 4h) cell lysate at 10 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

false

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)
  • WB

Supplier Data

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)

Blocking/Dilution buffer : 5% NFDM/TBST.

The lysates were prepared in 1%SDS Hot lysis method

All lanes:

Western blot - Anti-PARP1 antibody [EPR18461] (ab191217) at 1/1000 dilution

All lanes:

Mouse heart lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/50000 dilution

Predicted band size: 113 kDa

Observed band size: 113 kDa

false

Exposure time: 1min

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)
  • WB

Lab

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)

Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : PARP1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : MCF7 whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab191217 observed at 125 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab191217 was shown to specifically react with PARP1 when PARP1 knockout samples were used. Wild-type and PARP1 knockout samples were subjected to SDS-PAGE. ab191217 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/10000 dilution respectively. Blots were developed with 800CW Goat anti Rabbit and 680CW Goat anti Mouse secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PARP1 antibody [EPR18461] (ab191217)

Predicted band size: 113 kDa

false

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)
  • WB

Supplier Data

Western blot - Anti-PARP1 antibody [EPR18461] (AB191217)

Blocking/Dilution buffer : 5% NFDM/TBST.

The expression profile observed is consistent with what has been described in the literature (PMID : 1536009).

The lysates were prepared in 1%SDS Hot lysis method

All lanes:

Western blot - Anti-PARP1 antibody [EPR18461] (ab191217) at 1/10000 dilution

Lane 1:

Untreated NIH/3T3 (Mouse embryonic fibroblast cells) whole cell lysates at 10 µg

Lane 2:

NIH/3T3 (Mouse embryonic fibroblast cells) treated with 1uM staurosporine for 4 hours whole cell lysates at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 113 kDa

Observed band size: 113 kDa,55 kDa,89 kDa

false

Exposure time: 3min

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR18461

亚型

IgG

不含载体蛋白

No

反应种属

Mouse, Rat, Human

应用

ICC/IF, IHC-P, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" } } }

产品详情

What is this antibody validated in?
Anti-PARP1 antibody [EPR18461] (ab191217) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.

What is the molecular weight of PARP1?
Anti-PARP1 [EPR18461] (ab191217) specifically detects a band for PARP1 (UniProt: P09874) at a molecular weight of 113kDa.

Trusted by the scientific community
Anti-PARP1 [EPR18461] (ab191217) was first used in a scientific publication in 2015 and has been cited over 80 times in peer-reviewed journals.

Reviewed by scientists
Anti-PARP1 [EPR18461] (ab191217) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-PARP1 antibody [EPR18461] (ab191217) has been confirmed by Western blot testing in PARP1 Knockout HAP1 cell line, ab276094.

Other related products
We have a range of other formats of antibody clone [EPR18461] also available for your convenience: ab191217, Alexa Fluor® 488 - ab214954, Carrier free - ab222234, Alexa Fluor® 647 - ab311131, Alexa Fluor® 594 - ab311763, Alexa Fluor® 568 - ab313044, Alexa Fluor® 555 - ab313245, Alexa Fluor® 750 - ab321320

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

PARP1 also known as poly(ADP-ribose) polymerase 1 is an enzyme that plays an important role in DNA repair processes. It detects DNA single-strand breaks and uses NAD+ as a substrate to add ADP-ribose polymers to itself and other proteins. This post-translational modification signals DNA repair machinery to the site of damage. PARP1 has a molecular weight of approximately 116 kDa. It is widely expressed in the nucleus of eukaryotic cells. PARP1 is often studied by western blotting techniques to analyze its expression and activation levels.
Biological function summary

Poly(ADP-ribose) polymerase 1 functions to maintain genomic stability by acting within the base excision repair complex. This complex is important for the detection and repair of DNA damage preventing the accumulation of mutations. By acting at sites of DNA stress PARP1 facilitates the binding of DNA repair proteins stabilizing the DNA structure during the repair process. This role is significant for cells that undergo frequent DNA replication or are exposed to high levels of genotoxic stress.

Pathways

The PARP1 protein is integral to the DNA damage response and repair pathway. It interacts with other proteins such as XRCC1 to coordinate repair activities at damaged DNA sites. Another important pathway involving PARP1 is the apoptosis pathway where excessive activation of PARP1 can lead to cell death due to depletion of cellular NAD+ and ATP. This indicates its dual role in both promoting cell survival through DNA repair and contributing to cell death when damage is irreparable.

Poly(ADP-ribose) polymerase 1 is strongly linked to cancer and neurodegenerative diseases. Its activity is heightened in many cancer types where cancer cells exploit PARP1 for survival by repairing DNA damage that would otherwise be lethal. Inhibitors of PARP1 are being developed as cancer therapies to target these survival mechanisms. Moreover overactivation of PARP1 in neurodegenerative disorders like Alzheimer's disease can lead to excessive energy consumption promoting neuronal cell damage. In these contexts PARP1 connects with proteins like BRCA1 in cancer or AIF in neurodegeneration illustrating its role in disease mechanisms.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair (PubMed : 17177976, PubMed : 18055453, PubMed : 18172500, PubMed : 19344625, PubMed : 19661379, PubMed : 20388712, PubMed : 21680843, PubMed : 22582261, PubMed : 23230272, PubMed : 25043379, PubMed : 26344098, PubMed : 26626479, PubMed : 26626480, PubMed : 30104678, PubMed : 31796734, PubMed : 32028527, PubMed : 32241924, PubMed : 32358582, PubMed : 33186521, PubMed : 34465625, PubMed : 34737271). Mediates glutamate, aspartate, serine, histidine or tyrosine ADP-ribosylation of proteins : the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units (PubMed : 19764761, PubMed : 25043379, PubMed : 28190768, PubMed : 29954836, PubMed : 35393539, PubMed : 7852410, PubMed : 9315851). Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage (PubMed : 33186521, PubMed : 34874266). Specificity for the different amino acids is conferred by interacting factors, such as HPF1 and NMNAT1 (PubMed : 28190768, PubMed : 29954836, PubMed : 32028527, PubMed : 33186521, PubMed : 33589610, PubMed : 34625544, PubMed : 34874266). Following interaction with HPF1, catalyzes serine ADP-ribosylation of target proteins; HPF1 confers serine specificity by completing the PARP1 active site (PubMed : 28190768, PubMed : 29954836, PubMed : 32028527, PubMed : 33186521, PubMed : 33589610, PubMed : 34625544, PubMed : 34874266). Also catalyzes tyrosine ADP-ribosylation of target proteins following interaction with HPF1 (PubMed : 29954836, PubMed : 30257210). Following interaction with NMNAT1, catalyzes glutamate and aspartate ADP-ribosylation of target proteins; NMNAT1 confers glutamate and aspartate specificity (By similarity). PARP1 initiates the repair of DNA breaks : recognizes and binds DNA breaks within chromatin and recruits HPF1, licensing serine ADP-ribosylation of target proteins, such as histones (H2BS6ADPr and H3S10ADPr), thereby promoting decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks (PubMed : 17177976, PubMed : 18172500, PubMed : 19344625, PubMed : 19661379, PubMed : 23230272, PubMed : 27067600, PubMed : 34465625, PubMed : 34874266). HPF1 initiates serine ADP-ribosylation but restricts the polymerase activity of PARP1 in order to limit the length of poly-ADP-ribose chains (PubMed : 33683197, PubMed : 34732825, PubMed : 34795260). In addition to base excision repair (BER) pathway, also involved in double-strand breaks (DSBs) repair : together with TIMELESS, accumulates at DNA damage sites and promotes homologous recombination repair by mediating poly-ADP-ribosylation (PubMed : 26344098, PubMed : 30356214). Mediates the poly-ADP-ribosylation of a number of proteins, including itself, APLF, CHFR, RPA1 and NFAT5 (PubMed : 17396150, PubMed : 19764761, PubMed : 24906880, PubMed : 34049076). In addition to proteins, also able to ADP-ribosylate DNA : catalyzes ADP-ribosylation of DNA strand break termini containing terminal phosphates and a 2'-OH group in single- and double-stranded DNA, respectively (PubMed : 27471034). Required for PARP9 and DTX3L recruitment to DNA damage sites (PubMed : 23230272). PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites (PubMed : 23230272). PARP1-mediated DNA repair in neurons plays a role in sleep : senses DNA damage in neurons and promotes sleep, facilitating efficient DNA repair (By similarity). In addition to DNA repair, also involved in other processes, such as transcription regulation, programmed cell death, membrane repair, adipogenesis and innate immunity (PubMed : 15607977, PubMed : 17177976, PubMed : 19344625, PubMed : 27256882, PubMed : 32315358, PubMed : 32844745, PubMed : 35124853, PubMed : 35393539, PubMed : 35460603). Acts as a repressor of transcription : binds to nucleosomes and modulates chromatin structure in a manner similar to histone H1, thereby altering RNA polymerase II (PubMed : 15607977, PubMed : 22464733). Acts both as a positive and negative regulator of transcription elongation, depending on the context (PubMed : 27256882, PubMed : 35393539). Acts as a positive regulator of transcription elongation by mediating poly-ADP-ribosylation of NELFE, preventing RNA-binding activity of NELFE and relieving transcription pausing (PubMed : 27256882). Acts as a negative regulator of transcription elongation in response to DNA damage by catalyzing poly-ADP-ribosylation of CCNT1, disrupting the phase separation activity of CCNT1 and subsequent activation of CDK9 (PubMed : 35393539). Involved in replication fork progression following interaction with CARM1 : mediates poly-ADP-ribosylation at replication forks, slowing fork progression (PubMed : 33412112). Poly-ADP-ribose chains generated by PARP1 also play a role in poly-ADP-ribose-dependent cell death, a process named parthanatos (By similarity). Also acts as a negative regulator of the cGAS-STING pathway (PubMed : 32315358, PubMed : 32844745, PubMed : 35460603). Acts by mediating poly-ADP-ribosylation of CGAS : PARP1 translocates into the cytosol following phosphorylation by PRKDC and catalyzes poly-ADP-ribosylation and inactivation of CGAS (PubMed : 35460603). Acts as a negative regulator of adipogenesis : catalyzes poly-ADP-ribosylation of histone H2B on 'Glu-35' (H2BE35ADPr) following interaction with NMNAT1, inhibiting phosphorylation of H2B at 'Ser-36' (H2BS36ph), thereby blocking expression of pro-adipogenetic genes (By similarity). Involved in the synthesis of ATP in the nucleus, together with NMNAT1, PARG and NUDT5 (PubMed : 27257257). Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming (PubMed : 27257257).. Poly [ADP-ribose] polymerase 1, processed C-terminus. Promotes AIFM1-mediated apoptosis (PubMed : 33168626). This form, which translocates into the cytoplasm following cleavage by caspase-3 (CASP3) and caspase-7 (CASP7) in response to apoptosis, is auto-poly-ADP-ribosylated and serves as a poly-ADP-ribose carrier to induce AIFM1-mediated apoptosis (PubMed : 33168626).. Poly [ADP-ribose] polymerase 1, processed N-terminus. This cleavage form irreversibly binds to DNA breaks and interferes with DNA repair, promoting DNA damage-induced apoptosis.
See full target information PARP1

文献 (146)

Recent publications for all applications. Explore the full list and refine your search

Current issues in molecular biology 47: PubMed41020839

2025

The Anti-Tumor and Bortezomib-Sensitizing Effects of Apigenin in Multiple Myeloma.

Applications

Unspecified application

Species

Unspecified reactive species

Ye Chen,Lan Wu,Siyu Wang,Huihao Chen,Miaojun Chen,Yanfen Huang,Bin Ding

Frontiers in molecular neuroscience 18:1606973 PubMed40881324

2025

ACTN2, regulated by PRDM9, affects the growth and inflammation of vascular smooth muscle cells by interacting with PDLIM1 in intracranial aneurysms.

Applications

Unspecified application

Species

Unspecified reactive species

Guangxu Zhang,Jinbing Zhao,Zhiqiang Yu,Hongyi Liu

Experimental & molecular medicine 57:1686-1699 PubMed40744995

2025

Poly(ADP-ribose) polymerase 1 orchestrates vascular smooth muscle cell homeostasis in arterial disease.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjing Xu,Yichen Wu,Ruiqi Mao,Yujie Jia,Hao Jiang,Fengxiao Zhang,Dan Huang,Ximiao He,Cheng Wang,Kai Huang

Journal of clinical and translational hepatology 13:469-483 PubMed40474884

2025

Oleanolic Acid Restores Drug Sensitivity in Sorafenib-resistant Hepatocellular Carcinoma: Evidence from and Studies.

Applications

Unspecified application

Species

Unspecified reactive species

Tongtong Li,Xuan Shen,Tao Zhang,Jiaheng Ren,Wang Wang,Didi Wang,Pengxia Zhang

Journal of biochemical and molecular toxicology 39:e70268 PubMed40269590

2025

N-Acety-L-Cysteine Alleviates Isoflurane-Triggered Neuronal Cell Parthanatos by Suppressing Reactive Oxygen Species Accumulation Through the Induction of c-Jun N-Terminal Kinase Signaling Pathway Inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Liu,Ya Liu,Xuedong Wang,Ming Liu,Yingying Wang,Chunsheng Feng,Meihua Piao

Acta biochimica et biophysica Sinica 57:1492-1506 PubMed40259885

2025

Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer tumorigenesis via the miR-195-5p/IKBKB axis.

Applications

Unspecified application

Species

Unspecified reactive species

Bi Wang,Ling Li,Zhengyu Wu,Xuanzhen Qian,Wenfeng Yu,Zhi Huang

Cancer discovery 15:1037-1062 PubMed40199338

2025

Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes.

Applications

Unspecified application

Species

Unspecified reactive species

Carlota Arenillas,Lucía Celada,José Ruiz-Cantador,Bruna Calsina,Debayan Datta,Eduardo García-Galea,Roberta Fasani,Ana Belén Moreno-Cárdenas,Juan José Alba-Linares,Berta Miranda-Barrio,Ángel M Martínez-Montes,Cristina Alvarez-Escola,Beatriz Lecumberri,Ana González García,Shahida K Flores,Emmanuel Esquivel,Yanli Ding,Mirko Peitzsch,José-Ángel Robles-Guirado,Rita Maria Regojo Zapata,José Juan Pozo-Kreilinger,Carmela Iglesias,Trisha Dwight,Christopher A Muir,Amelia Oleaga,Maria Elvira Garrido-Lestache Rodríguez-Monte,Maria Jesús Del Cerro,Isaac Martínez-Bendayán,Enol Álvarez-González,Tamara Cubiella,Delmar Muniz Lourenço,Maria Adelaide A Pereira,Nelly Burnichon,Alexandre Buffet,Craig Broberg,Paxton V Dickson,Mario F Fraga,José Luis Llorente Pendás,Joaquín Rueda Soriano,Francisco Buendía Fuentes,Sergio P A Toledo,Roderick Clifton-Bligh,Rodrigo Dienstmann,Josep Villanueva,Jaume Capdevila,Anne-Paule Gimenez-Roqueplo,Judith Favier,Paolo Nuciforo,William F Young,Nicole Bechmann,Alexander R Opotowsky,Anand Vaidya,Irina Bancos,Donate Weghorn,Mercedes Robledo,Anna Casteràs,Laura Dos-Subirà,Igor Adameyko,María-Dolores Chiara,Patricia L M Dahia,Rodrigo A Toledo

Translational neuroscience 16:20250366 PubMed40026710

2025

Epigallocatechin gallate mitigates the motor deficits in a rotenone-induced Parkinson's disease rat model via promoting protein kinase D1 and inhibiting neuronal Parthanatos.

Applications

Unspecified application

Species

Unspecified reactive species

Jianjun Wang,Yaqi Tang,Chenwu Guo,Zekun Du,Fen Chen,Shujuan Fang,Yinjuan Tang

Pharmaceuticals (Basel, Switzerland) 18: PubMed40006027

2025

Recombinant Lectin Exerts Differential Proapoptotic Activity on EGFR and EGFR Colon Cancer Cells and Provokes T Cell-Assisted Antitumor Responses in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Francisco Luján-Méndez,Patricia García-López,Laura C Berumen,Guadalupe García-Alcocer,Roberto Ferriz-Martínez,Anette Ramírez-Carrera,Jaqueline González-Barrón,Teresa García-Gasca

Journal of nanobiotechnology 23:114 PubMed39962465

2025

RGD hydrogel-loaded ADSC extracellular vesicles mitigate uranium-induced renal injury via TLR4/NF-κB pathway inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Chen,Chun-Mei Dai,Bin Zhang,Wan-Xin Zhang,Zheng-Hong Huang,Jiu-Yi Jiang,Shi-Qi Hu,Jia-Hua Ma,Jia-Fu Feng
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com